How Much Is a Full Body CT Scan? Prices & Risks

A full body CT scan at a direct-to-consumer imaging center typically costs between $500 and $2,500 out of pocket, with most facilities charging somewhere around $1,000 to $1,500. Insurance rarely covers these scans when ordered without a specific medical indication, so you are almost always paying cash. The price tag, though, is only one piece of the cost picture. Radiation exposure, a high rate of incidental findings that trigger expensive follow-up testing, and potential contrast dye reactions all factor into the real expense and real risk of getting scanned head to toe.

What Drives the Price Range

The wide spread in pricing comes down to geography, the technology used, and what the facility bundles into its package. A basic low-dose CT scan of the chest, abdomen, and pelvis at a freestanding imaging center in a mid-sized city may land closer to the $500 end. A premium package at a boutique wellness clinic in a major metro area, complete with a radiologist consultation, a detailed report, and follow-up appointment, can push past $2,000. Some centers also offer add-ons like a coronary calcium score or a virtual colonoscopy for an additional fee.

One thing to watch for is the voucher and deal-site model. A study examining online vouchers for discounted direct-to-consumer imaging found that only about two-thirds of the companies selling these vouchers mentioned that a consultation would be required to assess eligibility, and none included that detail in their advertisements elsewhere.¹ That means you could buy a discounted scan and then discover you need a separate paid visit before anything happens. The sticker price on a voucher is not always the final price.

It is also worth separating full body CT from full body MRI, which has gained popularity through companies marketing preventive screening. MRI does not use ionizing radiation, but it costs more, often $2,000 to $5,000 or higher. When people talk about “getting a full body scan,” they sometimes mean MRI, but the technology, risks, and cost profile are quite different. This article focuses on CT.

How Much Radiation a Full Body CT Delivers

A full body CT scan exposes you to a meaningful dose of ionizing radiation. The effective dose from a whole-body low-dose CT protocol has been measured at roughly 5 millisieverts (mSv), which is more than double a standard skeletal X-ray survey and about 25 percent higher than a contrast-enhanced chest CT alone.² For context, the average American picks up about 3 mSv per year from natural background radiation, so a single whole-body scan roughly doubles your annual exposure in one sitting.

Standard-dose full body CT protocols can push higher than that 5 mSv figure. The dose depends heavily on the machine settings, your body size, and whether contrast dye is used. A contrast-enhanced abdomen and pelvis CT alone can deliver around 9 mSv, and a full body protocol that images the chest, abdomen, and pelvis at standard diagnostic settings can exceed 10 mSv or more. Low-dose protocols trade some image sharpness for lower radiation, and studies comparing low-dose to standard-dose CT for evaluating specific findings have found near-identical diagnostic accuracy.³ If you are going to get a whole-body scan, asking whether the facility uses a low-dose protocol is a reasonable question.

Cancer Risk From the Radiation

The radiation from a CT scan is not just an abstract number. Researchers have modeled what it means for your long-term cancer risk. A single full body CT in a 45-year-old adult carries an estimated lifetime attributable cancer mortality risk of about 0.08 percent. That sounds small, and it is. But it is not zero. And it scales with repetition: a 45-year-old who gets annual full body CT scans through age 75, accumulating 30 scans, would face an estimated lifetime cancer death risk of about 1.9 percent from the radiation alone.⁴

The risk is also higher for younger people. A study estimating cancer incidence risk from whole-body PET/CT found that for 20-year-old women, the lifetime attributable risk of developing a radiation-induced cancer ranged from about 0.23 to 0.51 percent from a single scan, with somewhat lower figures for men of the same age. The risk dropped as the age at exposure increased.⁵ This makes intuitive sense: younger bodies have more dividing cells and more remaining years for a radiation-triggered mutation to develop into a cancer. The upshot is that a one-time screening scan for a 55-year-old is a very different risk proposition than an annual scan for a 30-year-old who plans to keep doing it every year.

These risk estimates carry wide uncertainty bands, and reasonable scientists disagree about whether very low doses of radiation cause cancer at all or whether there is a threshold below which the risk is effectively zero. But most radiation protection guidelines treat any dose as carrying some incremental risk, and the numbers above reflect that framework.

Incidental Findings and the Cascade They Trigger

Perhaps the least intuitive risk of a full body CT scan is what happens when the scan finds something. Not something dangerous, necessarily, but something. CT scanners are extraordinarily detailed, and when you image an entire body, you generate an enormous amount of data. Hidden within that data are benign cysts, small nodules, anatomical variants, and other findings that have nothing to do with your health but that a radiologist is obligated to report.

Across diagnostic imaging studies, the average rate of incidental findings sits around 24 percent. For CT specifically, that rate climbs to roughly 31 percent.⁶ Other estimates put the range at 20 to 40 percent for CT examinations.⁷ That means if you walk into a scanning center feeling perfectly healthy, there is roughly a one-in-three chance the radiologist will flag something that needs follow-up, even though it was not the reason you came in.

Most incidental findings turn out to be harmless. A small kidney cyst, a benign liver hemangioma, a thyroid nodule that will never cause trouble. But once something is seen and documented, clinical guidelines generally call for follow-up imaging, blood tests, specialist consultations, or biopsies to rule out something serious. You cannot unsee a finding, and neither can your medical record.

The Financial and Physical Cost of Follow-Up

Those follow-up procedures add up quickly. A study of asymptomatic people who received non-contrast abdominal CT scans found that follow-up procedures, including additional imaging, consultations, and surgeries, cost an average of roughly 2,000 Swiss francs (a comparable figure in US dollars) per participant. For those whose incidental findings required active follow-up, the average cost per finding was about 3,000 francs. Three participants needed surgery, with individual surgical costs reaching over 35,000 francs in one case.⁸

A separate study looking at incidental findings during a lung cancer screening program found that the most common follow-up recommendations were for additional imaging of the thyroid and kidneys, with ultrasound being the most frequent follow-up test. About 1.5 percent of participants ended up needing surgery because of incidental findings. Six malignancies were ultimately diagnosed, at a rate of 0.2 percent per year.⁹ That is real cancer caught by scanning, which sounds like a win. But it also means that for every cancer found, many more people underwent biopsies, follow-up scans, anxiety-inducing wait times, and medical bills for findings that turned out to be nothing.

This cascade effect is the hidden cost that the initial price tag does not reflect. You might pay $1,000 for the scan, but if it surfaces an incidental finding, you could easily spend several thousand more in follow-up care, most of which your insurance may or may not cover depending on how the subsequent workups are coded.

Contrast Dye Reactions

Not every full body CT uses intravenous contrast dye, but many do, especially when the goal is to get a clearer look at blood vessels, organs, and potential tumors. Contrast agents improve the scan’s ability to distinguish between different tissues, but they carry their own side effects.

Most reactions to iodinated contrast media are mild: warmth or flushing during injection, a metallic taste, or mild nausea. Allergic-type hypersensitivity reactions occur in a small percentage of patients. A systematic review of one commonly used contrast agent found that adverse drug reactions occurred in a median of about 1.7 percent of adults, with hypersensitivity reactions in roughly 0.2 to 0.7 percent. Severe reactions were rare, with a median incidence of zero across most studies.¹⁰

The more concerning side effect is contrast-induced kidney injury, which typically shows up 24 to 72 hours after the scan as a spike in creatinine levels. This is most likely to happen in people who already have impaired kidney function or diabetes.¹¹ If you have healthy kidneys and no significant medical history, the risk is low. But direct-to-consumer imaging centers do not always screen for kidney function before administering contrast, which is one reason medical societies have expressed concern about these services.

What the Marketing Typically Omits

The commercial full body scan industry has a transparency problem. Research examining how direct-to-consumer imaging services advertise has found that marketing materials overwhelmingly emphasize the technology and the reassurance of a clean result, while almost never mentioning the risks. In one analysis of companies selling imaging vouchers online, nearly half made unsubstantiated health claims, and only a single company out of 84 mentioned the potential risks of the imaging itself.¹

An earlier study of CT and MRI advertising found a similar pattern: promotional materials emphasized health information and technological sophistication, offered reassurances, and encouraged consumers to seek further details from company resources. Virtually none referred to independent sources of information or to the risks of having a scan.¹² This creates a lopsided picture where the consumer hears only the potential upside of early detection without learning about radiation exposure, incidental findings, or the downstream cascade of follow-up care.

This does not mean every direct-to-consumer scanning center is disreputable. Some are staffed by board-certified radiologists who use low-dose protocols and provide thoughtful consultations. But the marketing ecosystem as a whole does a poor job of informed consent compared to what you would receive in a hospital-based radiology department, where a referring physician has already weighed whether the scan’s benefits outweigh its risks for your specific situation.

The Dose You Get Depends on Where You Go

One underappreciated variable is how much the radiation dose varies from facility to facility for the same type of scan. A large study examining CT doses across multiple institutions found that effective doses varied by an average of 13-fold between the highest-dose and lowest-dose facility for each type of CT study. Even mean doses across institutions differed by two-fold or more, and for several scan types, the difference was three-fold or greater.¹³

This means two people getting the same “full body CT scan” at two different centers could receive wildly different radiation exposures. The reasons include differences in scanner hardware, software protocols, the technologist’s choices about settings, and whether the facility has optimized its protocols for dose reduction. Newer scanners with iterative reconstruction algorithms can produce diagnostic-quality images at substantially lower doses than older machines. If you are going to pay out of pocket for a scan, asking the facility what their typical effective dose is for a whole-body protocol is a reasonable step. If they cannot or will not answer, that tells you something about their quality practices.

Psychological Effects of Screening

Getting scanned can change how you feel, and not always in the direction you would expect. A systematic review examining the psychological effects of low-dose CT lung cancer screening found moderate evidence that, overall, people who underwent screening did not experience worse quality of life, anxiety, or distress over two years compared to people who were not screened. That is the good news. The more nuanced finding was that results mattered: people who received a true positive (actual cancer detected) had worse quality of life and anxiety, at least in the short term. And people who received an indeterminate result, where the scan found something but nobody could say yet whether it was dangerous, reported higher distress than those with clear-cut results in either direction.¹⁴

Indeterminate results are exactly what incidental findings produce. You went in healthy, the scan found a 6-millimeter lung nodule, and now you need a follow-up scan in three to six months to see if it grows. For many people, that waiting period is genuinely distressing, even though the vast majority of small nodules turn out to be benign. The psychological burden of living in diagnostic limbo is real and rarely discussed in the marketing materials.

When a Clean Scan Backfires

There is also a paradox at the other end: what happens when the scan shows nothing. Some people respond to a normal result by feeling motivated to take better care of themselves. But the evidence suggests this is not universal. Research has found that some individuals who receive a normal CT scan are actually less likely to make healthy changes. In studies of smokers, for example, people who received a clean lung CT were less motivated to quit smoking than those who had not been scanned.¹⁵

The mechanism is not hard to imagine. A clean bill of health from an advanced imaging scan can feel like a license to continue whatever you are doing. If your lungs “look fine” on a CT, why bother quitting? The scan becomes a substitute for behavior change rather than a motivator for it. This false sense of security is one of the softer risks of elective screening, harder to quantify than radiation dose but potentially more consequential for long-term health. A scan captures one moment in time. It cannot tell you that a cancer will not develop next year, or that your coronary arteries are not accumulating plaque that has not yet become visible on imaging.

Who Might Actually Benefit

None of this means full body CT scans are never useful. Evidence-based screening CT exists for specific populations. Low-dose CT lung cancer screening, for example, is recommended by the US Preventive Services Task Force for adults aged 50 to 80 who have a significant smoking history. In that population, the benefit of catching lung cancer early has been shown to outweigh the risks of radiation, incidental findings, and follow-up procedures. Similarly, CT coronary calcium scoring has established value in cardiovascular risk assessment for certain intermediate-risk individuals.

The gap in the evidence is for asymptomatic, average-risk people getting whole-body scans with no specific clinical question. No major medical society currently recommends routine full body CT screening for the general population. The American College of Radiology, the American Medical Association, and the FDA have all raised concerns about the practice. Their objection is not that CT technology is bad; it is that the benefit-to-harm ratio has not been demonstrated for blanket screening in people without symptoms or risk factors. The scans are very good at finding things. The problem is that most of what they find in healthy people does not need to be found.

If you are considering a full body CT scan, the honest accounting goes beyond the sticker price. Add the possibility of several thousand dollars in follow-up testing for incidental findings, a small but real increase in lifetime cancer risk from radiation, potential contrast dye reactions if contrast is used, and the psychological weight of indeterminate results. For some people, that trade-off will still feel worthwhile. But the decision should be made with full information, not just the version the marketing presents.